NCI
Biden Cancer Moonshot Announces New Projects Focused on Decreasing Cancer Burden in Africa
Programs aim to improve screening tools and adherence, advance new point-of-care diagnostics, and increase access to precision medicine on the continent.
UCLA Receives $1.8M NIH Grant to Validate Radiation Side Effect Biomarkers in Prostate Cancer
The researchers aim to validate a previously identified biomarker, called PROSTOX, that can predict urinary issues after radiation therapy.
Foundation for the NIH Consortium Launches Multiple Myeloma Biomarker Discovery Project
In the three-year, $4.5 million effort, the foundation aims to accelerate development of biomarkers that identify patients at high risk for multiple myeloma.
Researchers call for more data sharing from single-cell RNA sequencing studies to help validate machine learning precision medicine tools.
Early IDENTIFY Trial Results Suggest Half of Women With Non-Reportable NIPT Result Have Cancer
At the American College of Medical Genetics and Genomics annual meeting, NICHD Director Diana Bianchi reported that whole-body MRI was the best follow-up test to confirm or rule out cancer.